|
Fang, H; Liu, X; RamÃrez, J et al. (2014) Establishment of CYP2D6 reference samples by multiple validated genotyping platforms. Pharmacogenomics J 14:564-72
|
|
Thangavel, Chellappagounder; Boopathi, Ettickan; Shapiro, Bernard H (2013) Inherent sex-dependent regulation of human hepatic CYP3A5. Br J Pharmacol 168:988-1000
|
|
Noreault-Conti, Trisha L; Fellows, Abigail; Jacobs, Judith M et al. (2012) Arsenic decreases RXR?-dependent transcription of CYP3A and suppresses immune regulators in hepatocytes. Int Immunopharmacol 12:651-6
|
|
Ross, Matthew K; Borazjani, Abdolsamad; Wang, Ran et al. (2012) Examination of the carboxylesterase phenotype in human liver. Arch Biochem Biophys 522:44-56
|
|
Anderson, Linnea E; Dring, Ann M; Hamel, Laura D et al. (2011) Modulation of constitutive androstane receptor (CAR) and pregnane X receptor (PXR) by 6-arylpyrrolo[2,1-d][1,5]benzothiazepine derivatives, ligands of peripheral benzodiazepine receptor (PBR). Toxicol Lett 202:148-54
|
|
Singh, Rashmi; Bullard, Jay; Kalra, Mamta et al. (2011) Status of bacterial colonization, Toll-like receptor expression and nuclear factor-kappa B activation in normal and diseased human livers. Clin Immunol 138:41-9
|
|
Chaudhry, Amarjit S; Urban, Thomas J; Lamba, Jatinder K et al. (2010) CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance dose. J Pharmacol Exp Ther 332:599-611
|
|
Han, Shuxin; Li, Tiangang; Ellis, Ewa et al. (2010) A novel bile acid-activated vitamin D receptor signaling in human hepatocytes. Mol Endocrinol 24:1151-64
|
|
Yang, Xia; Zhang, Bin; Molony, Cliona et al. (2010) Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res 20:1020-36
|
|
Song, Kwang-Hoon; Li, Tiangang; Owsley, Erika et al. (2009) Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression. Hepatology 49:297-305
|
Showing the most recent 10 out of 65 publications
